The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.

The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...

In a localized area somewhat above the apical ... is emphasized as a diagnostic sign of aortic stenosis or calcification of the aortic valve. In the diagnosis of aortic stenosis the rough quality ...

For patients with symptomatic aortic regurgitation at high surgical risk, a transcatheter aortic valve replacement system exceeded safety and performance goals, according to results of the ALIGN-AR ...

Transcatheter aortic valve implantation (TAVI) has demonstrated survival and quality of life benefit in non-operative candidates with severe symptomatic aortic stenosis. Success in TAVI is ...

Check out our weekly list of new fundraisers from Lend A Hand Up, a nonprofit crowdfunding site supporting families in Cass, Steele, Traill, Grand Forks, Clay, Otter Tail and Becker Counties burdened ...

This promises considerable advantages for patient safety and efficiency in the treatment of high-grade aortic valve stenosis ... Vascular complications in the area of the access routes are ...

Background: Symptomatic severe aortic stenosis (AS) remains undertreated with high resultant ... with findings potentially indicative of severe AS with aortic valve area ≤ 1.0 cm 2 were enrolled.

Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with TTVR ...